Embryonic/fetal mortality and intrauterine growth restriction is not exclusive to the CBA/J sub-strain in the CBA × DBA model.

Kelly J McKelvey, Vanessa M Yenson, Anthony W Ashton, Jonathan M Morris, Sharon A McCracken
Author Information
  1. Kelly J McKelvey: Division of Perinatal Medicine, Kolling Institute, Northern Sydney Local Health District, St Leonards, 2065 NSW, Australia.
  2. Vanessa M Yenson: Division of Perinatal Medicine, Kolling Institute, Northern Sydney Local Health District, St Leonards, 2065 NSW, Australia.
  3. Anthony W Ashton: Division of Perinatal Medicine, Kolling Institute, Northern Sydney Local Health District, St Leonards, 2065 NSW, Australia.
  4. Jonathan M Morris: Division of Perinatal Medicine, Kolling Institute, Northern Sydney Local Health District, St Leonards, 2065 NSW, Australia.
  5. Sharon A McCracken: Division of Perinatal Medicine, Kolling Institute, Northern Sydney Local Health District, St Leonards, 2065 NSW, Australia.

Abstract

Inbred strains of mice are powerful models for understanding human pregnancy complications. For example, the exclusive mating of CBA/J females to DBA/2J males increases fetal resorption to 20-35% with an associated decline in placentation and maintenance of maternal Th1 immunity. More recently other complications of pregnancy, IUGR and preeclampsia, have been reported in this model. The aim of this study was to qualify whether the CBA/CaH substrain female can substitute for CBA/J to evoke a phenotype of embryonic/fetal mortality and IUGR. (CBA/CaH × DBA/2J) F1 had significantly higher embryonic/fetal mortality mortality (p = 0.0063), smaller fetuses (p < 0.0001), and greater prevalence of IUGR (<10 percentile; 47% vs 10%) than (CBA/CaH × Balb/c) F1. Placentae from IUGR fetuses from all mating groups were significantly smaller (p < 0.0001) with evidence of thrombosis and fibrosis when compared to normal-weight fetuses ( > 10 percentile). In addition, placentae of "normal-weight" (CBA/CaH × DBA/2J) F1 were significantly smaller (p < 0.0006) with a greater proportion of labyrinth (p = 0.0128) and an 11-fold increase in F4/80 + macrophage infiltration (p < 0.0001) when compared to placentae of (CBA/CaH × Balb/c) F1. In conclusion, the embryonic/fetal mortality and IUGR phenotype is not exclusive to CBA/J female mouse, and CBA/CaH females can be substituted to provide a model for the assessment of novel therapeutics.

References

  1. Theriogenology. 2006 Oct;66(6-7):1694-8 [PMID: 16554089]
  2. Reprod Suppl. 2001;58:223-32 [PMID: 11980192]
  3. J Immunol. 1987 Jul 1;139(1):85-8 [PMID: 3584989]
  4. Am J Obstet Gynecol. 2006 Jan;194(1):113-9 [PMID: 16389019]
  5. Immunogenetics. 1989;29(3):155-60 [PMID: 2522413]
  6. Placenta. 2014 Sep;35(9):696-701 [PMID: 25052232]
  7. Kidney Int. 2011 Feb;79(3):331-9 [PMID: 20944547]
  8. Obstet Gynecol. 1969 Jan;33(1):11-9 [PMID: 5813103]
  9. Hum Reprod Update. 2012 Jul;18(4):458-71 [PMID: 22523109]
  10. J Assoc Res Otolaryngol. 2010 Dec;11(4):605-23 [PMID: 20706857]
  11. Proc Natl Acad Sci U S A. 2011 Mar 8;108(10):4012-7 [PMID: 21300875]
  12. Arterioscler Thromb Vasc Biol. 2005 Jan;25(1):102-8 [PMID: 15499040]
  13. J Reprod Fertil. 1971 Jun;25(3):417-24 [PMID: 5579694]
  14. J Physiol. 2009 Jul 15;587(Pt 14):3453-8 [PMID: 19451203]
  15. PLoS One. 2010 Oct 27;5(10):e13663 [PMID: 21048973]
  16. Biol Reprod. 2013 Nov 21;89(5):120 [PMID: 24108302]
  17. J Reprod Fertil. 1965 Feb;9:79-98 [PMID: 14257721]
  18. J Reprod Immunol. 2011 May;89(2):163-72 [PMID: 21329986]
  19. J Immunogenet. 1989 Jun;16(3):223-31 [PMID: 2614072]
  20. Hum Reprod. 1998 Oct;13(1O):2941-9 [PMID: 9804259]
  21. Am J Anat. 1964 May;114:539-49 [PMID: 14167175]
  22. World Health Organ Tech Rep Ser. 1995;854:1-452 [PMID: 8594834]
  23. Pediatrics. 2010 Apr;125(4):e891-8 [PMID: 20308216]
  24. Pediatrics. 2006 Jul;118(1):91-100 [PMID: 16818553]
  25. Am J Reprod Immunol. 1994 Jan;31(1):47-51 [PMID: 8166947]
  26. Clin Obstet Gynecol. 2006 Jun;49(2):236-56 [PMID: 16721104]
  27. J Anat. 2009 Jul;215(1):21-6 [PMID: 19215319]
  28. BJOG. 2004 Oct;111(10):1031-41 [PMID: 15383103]
  29. J Pathol. 2012 Nov;228(3):322-32 [PMID: 22653829]
  30. Cell Immunol. 1980 Jun;52(1):106-18 [PMID: 6446406]
  31. Reprod Biol Endocrinol. 2008 Aug 12;6:34 [PMID: 18700008]
  32. PLoS One. 2010 Aug 25;5(8):e12418 [PMID: 20811634]
  33. Pediatrics. 2003 Jan;111(1):e61-6 [PMID: 12509596]
  34. J Exp Med. 2014 Jan 13;211(1):165-79 [PMID: 24395887]
  35. Am J Pathol. 2006 Nov;169(5):1863-74 [PMID: 17071607]
  36. J Exp Med. 2006 Sep 4;203(9):2165-75 [PMID: 16923853]
  37. Reprod Biol Endocrinol. 2014 May 10;12 :38 [PMID: 24886361]
  38. Placenta. 2009 Jun;30(6):473-82 [PMID: 19375795]

MeSH Term

Animals
Disease Models, Animal
Female
Fetal Growth Retardation
Fetal Mortality
Fetal Resorption
Mice
Mice, Inbred BALB C
Mice, Inbred CBA
Mice, Inbred DBA
Placenta
Pregnancy
Pregnancy Complications

Word Cloud

Created with Highcharts 10.0.0IUGRmortalityCBA/JF1p < 0exclusivemodelembryonic/fetalsignificantlysmallerfetuses0001pregnancycomplicationsmatingfemalesCBA/CaHfemalecanphenotypeCBA/CaH × DBA/2Jp = 0greaterpercentileCBA/CaH × Balb/ccomparedplacentaeInbredstrainsmicepowerfulmodelsunderstandinghumanexampleDBA/2Jmalesincreasesfetalresorption20-35%associateddeclineplacentationmaintenancematernalTh1immunityrecentlypreeclampsiareportedaimstudyqualifywhethersubstrainsubstituteevokehigher0063prevalence<1047%vs10%Placentaegroupsevidencethrombosisfibrosisnormal-weight > 10addition"normal-weight"0006proportionlabyrinth012811-foldincreaseF4/80 + macrophageinfiltrationconclusionmousesubstitutedprovideassessmentnoveltherapeuticsEmbryonic/fetalintrauterinegrowthrestrictionsub-strainCBA × DBA

Similar Articles

Cited By